Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07786857

Intraoperative Glycemic Variability and Infectious Complications After Liver Transplantation

This study aims to evaluate whether intraoperative glycemic variability (GV) is independently associated with the risk of infectious complications within 30 days after elective liver transplantation. This is an observational study with no intervention beyond standard perioperative care. Glycemic and clinical outcome data will be obtained from routinely collected medical records of patients undergoing liver transplantation at the 2nd Department of Anesthesiology and Intensive Care, Medical University of Warsaw.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Liver Transplantation (LT) Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Surgical Wound Infection Wound Infection

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age over 18 years
  • Elective orthotopic liver transplantation

Exclusion criteria

  • Liver retransplantation
  • multi-organ transplantation
  • Urgent/emergency transplantation
  • Active infection under antibiotic treatment at the time of surgery
  • Preoperative systemic inflammatory response syndrome (SIRS)
  • Incomplete intraoperative glycemic data
  • Pregnancy
  • Participation in another interventional study that could affect glycemic control or infection risk

Treatment and study plan

Primary outcomes

  1. Occurrence of at least one infectious complication within 30 days after liver transplantation

    Time frame: 30 days

    Binary outcome (yes/no), including: pneumonia (clinical, radiological, and microbiological criteria), urinary tract infection (clinical symptoms + positive urine culture), surgical site infection per CDC criteria, sepsis/septic shock per Sepsis-3 criteria.

Study contacts

Contact information is provided by the study sponsor or research team.

Paula Dudek, MD

CONTACT

[email protected]

+225992002

Sponsors and collaborators

Lead sponsor

Medical University of Warsaw

Other

Registry information

Official study title

Intraoperative Glycemic Variability and the Risk of Infectious Complications After Elective Liver Transplantation: A Prospective Cohort Study

Acronym: SUGAR-LT

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 26, 2026
Registry last updated
Aug 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.